ArticleCancer management and research2025

Preclinical and Case Series Studies on the Combination of Venetoclax with Epigenetic Drugs in T-Cell Acute Lymphoblastic Leukemia.

Boyue Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.